Trial Profile
Open Label, Multi-Center Evaluation of Nitazoxanide for the Treatment of Cryptosporidiosis in Subjects With AIDS in the United States
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Cryptosporidiosis
- Focus Therapeutic Use
- Sponsors Romark Laboratories
- 10 May 2014 New trial record